Exelixis Inc. and Ipsen announced detailed results of the pivotal phase III CELESTIAL trial in patients with previously treated advanced hepatocellular carcinoma, which will be presented in a late-breaking oral session at the 2018 ASCO-GI Symposium.
James AllisonAdriaan Bax,Jennifer A. DoudnaHoward Y. Chang,James Allison, of MD Anderson Cancer Center, will receive the Jessie Stevenson Kovalenko Medal from the National Academy of Sciences.
Kathy Albain was named the inaugural Huizenga Family Endowed Chair in Oncology Research at Loyola University Chicago Stritch School of Medicine.
The Centers for Medicare and Medicaid Services issued guidance allowing states to require “able-bodied” adults to work, participate in job training or volunteer in order to receive Medicaid health benefits.
Amidst a dramatically changing healthcare landscape and increasingly competitive market, the Association of Community Cancer Centers eighth annual Trending Now in Cancer Care survey, which was conducted in partnership with Advisory Board's Oncology Roundtable, identifies current and emerging trends across U.S. cancer programs.
As the rancor in Washington continues to escalate from bickering to a war on many fronts, the deadline approaches for the end of a continuing resolution that keeps the federal government open until Jan. 19.
The recent FDA approvals of a cell/gene therapy for patients with advanced B cell malignancies provide a glimpse into a paradigm shift in the treatment of hematologic and solid cancers, the creation of a new drug unique to each cancer patient.
FDA expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of metastatic breast cancer whose tumors have a specific germline mutation.
Specialty diagnostics company Precipio Inc. announced preliminary data from an ongoing study on the impact of academic pathology expertise on diagnostic accuracy.
Researchers at UT Southwestern's Simmons Cancer Center have shown that RAS molecules act in pairs, known as dimers, to cause cancer, findings that could help guide them to a treatment.
